STAT

APRIL 26, 2023

When Cecilia Sorensen was an emergency medicine resident practicing at Denver Health in Colorado a few years ago, summer was known as “trauma season.” Gunshot and motor vehicle accident victims, people with heart attacks and COPD would stream into the ER. Later, on a fellowship, she witnessed the health impacts of drought in Syria. The common driver, she realized, was climate change and its impact, both locally and globally.

290

290

PharmaVoice

APRIL 26, 2023

Drug developers have tried — and failed — to create a male contraceptive for decades. Now, one group of scientists might be on the verge of success.

Drug Development 148

Drug Development 148

BioPharma Dive

APRIL 26, 2023

Accessing the Illinois facility will expand Bristol Myers’ supply of viral vectors following manufacturing struggles with CAR-T drugs Abecma and Breyanzi.

126

126

PharmaVoice

APRIL 26, 2023

From startup to potential standout in the chronic cough space, Good is creating a new way of treating the unmet needs of patients.

130

130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Technology

APRIL 26, 2023

AstraZeneca , Teva Pharmaceuticals , and Novartis , and other companies, are expanding their reach in the asthma space by capitalizing on digital technologies to enhance the patient experience. But experts say the complete integration of these devices and platforms into the healthcare system remains to be seen. Dr. Amy Chan, senior clinical research fellow at the School of Pharmacy, University of Auckland, says digital inhalers have existed for almost 30 years.

Medication Delivery 115

Medication Delivery Communication Drug Development 115

BioPharma Dive

APRIL 26, 2023

Founded by Howard Chang, John Maraganore and others, the RNA-focused startup drew investment from a large group of blue-chip venture investment firms.

125

125

BioPharma Dive

APRIL 26, 2023

The drug is the first microbiota-based pill to win U.S. approval. Like a rival therapy approved in December, it’s for difficult-to-treat C. diff infections.

117

117

The Pharmacist

APRIL 26, 2023

The National Pharmacy Association (NPA) has announced that it does not support the new Pharmacy Contraception Service and believes that both patients and pharmacies will lose out if the service is continued. NHS England and contractors should ‘pause and reflect’ before further implementation of the Pharmacy Contraception Service, the organisation added.

93

93

PhRMA

APRIL 26, 2023

Today PhRMA joins with innovators around the globe to recognize World IP Day and celebrate biopharmaceutical innovators who dedicate their lives to bringing new treatments and cures to patients. It’s also a day to reflect on the role Intellectual Property (IP) protections, such as patents, play in supporting the development of cutting-edge technologies.

94

94

The Pharmacist

APRIL 26, 2023

NHS England has announced the expansion of the 'soups and shakes' weight loss programme for type 2 diabetes patients to all parts of England from March next year. The scheme was being rolled out nationwide because initial data from the programme shows ‘early promise’ it might lead to diabetes remission in ‘up to half’ of […] The post 'Promising' diabetes programme to roll out across England appeared first on The Pharmacist.

Diabetes 88

Diabetes 88

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

European Pharmaceutical Review

APRIL 26, 2023

Oral iptacopan enabled an estimated 92.2 percent of complement-inhibitor-naïve, paroxysmal nocturnal haemoglobinuria (PNH) patients achieve 2 g/dL or more haemoglobin-level increase from baseline without the need for blood transfusions. The results show “oral iptacopan controls haemolysis while nearly eliminating the need for blood transfusions” These data from the Phase III APPOINT-PNH trial were presented at the 2023 Annual Meeting of the European Society for Blood and Marrow Transplantation (

Hospitals 84

Hospitals 84

The Pharmacist

APRIL 26, 2023

A campaign group has launched a series of ‘bite-sized’ educational videos for GPs and pharmacists to increase understanding of the menopause and the treatment options available. The ‘Meno-series’ videos, created by Menopause Mandate, feature community pharmacist Thorrun Govind and GP Dr Juliet Balfour, a British Menopause Society accredited menopause specialist and trainer.

71

71

PharmaTech

APRIL 26, 2023

Mariano Mattei, vice-president of cybersecurity and CISO for Azzur Group, goes in depth about cybersecurity in the pharma field.

98

98

World Pharma News

APRIL 26, 2023

The University of Cincinnati's Soma Sengupta, MD, PhD, published an article in the Journal of Neuro-Oncology April 25 discussing her journey and approach to practicing integrative neuro-oncology.

82

82

Pharma Times

APRIL 26, 2023

Vital link-up aims to expand ColoAlert detection tests in Europe and increase early cancer diagnosis

95

95

Express Pharma

APRIL 26, 2023

Akums Drugs and Pharmaceutical has announced the launch of its latest formulation, a unique Combikit – (Amoxicillin + Clarithromycin + Esomeprazole). This Combikit is the first of its kind to be introduced in India by Akums. Combikit (Amoxicillin + Clarithromycin + Esomeprazole) is approved by the CDSCO for the healing of duodenal ulcers associated with Helicobacter pylori (H. pylori) and eradication of H. pylori in patients with active or healed peptic ulcer.

76

76

Pharma Times

APRIL 26, 2023

Recommendation concerns routine use across the NHS as therapy for multiple myeloma

102

102

Pharmafile

APRIL 26, 2023

The US Food and Drug Administration (FDA) has released a Public Safety Notification on eyedrops containing amniotic fluid currently being sold to treat, mitigate or cure diseases or conditions including dry eye disease. This safety notice links to earlier letters to two manufacturers, Regener-Eyes and StimulEyes, which warned that they would need an approved Biologics License Application (BLA) for these products to be kept on the market, otherwise an investigational new drug (IND) application wo

Communication 71

Communication 71

Express Pharma

APRIL 26, 2023

Nkure Therapeutics, an NK cell therapy company, announced the closure of its pre–Series A round with participation from Endiya Partners, Kotak Investment Advisors, Featherlite and a few angel investors. Nkure expects to use the investments to complete its manufacturing protocols and complete its preclinical studies for its planned IND submission. Nkure was founded in 2022 by Dr Mahendra Rao (previously Founding Director of the Centre for Regenerative Medicine at the NIH, US) and is supported by

72

72

EMCrit Project

APRIL 26, 2023

Is there an easier way to mix up push-dose epinephrine that is still as safe? EMCrit Project by Scott Weingart, MD FCCM.

87

87

BioPharma Dive

APRIL 26, 2023

Commercial chief Christopher Boerner will take over after spending the next six months as chief operating officer. Caforio will continue to serve as chair of Bristol Myers’ board.

68

68

Pharmaceutical Technology

APRIL 26, 2023

Biotechnology company Adcentrx Therapeutics has raised $38m in Series A+ financing to advance its pipeline of new antibody-drug conjugate (ADC) therapeutics into clinical development. Lighthouse Capital and Life Venture Partners served as financial advisors to the company. Led by Eight Roads Ventures, the financing round saw participation from strategic investors, including the Trinity Innovation Fund, ABio-X, Delta Capital and F-Prime Capital.

59

59

Pharmafile

APRIL 26, 2023

US-based medical devices and healthcare company Abbott has announced two new clearances from the US Food and Drug Administration (FDA) for its life support system. The CentriMag Blood Pump, for use with the CentriMag System, is now cleared for longer-term use in adults when extracorporeal membrane oxygenation (ECMO) is critical to saving their life ‒ ECMO is a type of life support which replaces heart and lung function when these have failed.

Communication 58

Communication 58

Express Pharma

APRIL 26, 2023

Takeda Biopharmaceuticals  has been certified as a Great Place To Work in India (March 2023 – March 2024). This certification has been awarded second time in a row to Takeda. Commenting on the recognition, Serina Fischer, General Manager, Takeda Biopharmaceuticals India said, “We remain steadfast in providing a fair, equitable, and non-discriminatory workplace where our people can be their own true selves and contribute meaningfully to solving complex challenges as we seek to improve

57

57

BioPharma Dive

APRIL 26, 2023

One year after its market debut, the company’s AMD drug Vabysmo is on track for blockbuster sales as Regeneron’s rival treatment faces new threats.

59

59

pharmacy mentor

APRIL 26, 2023

The rapid advancement of artificial intelligence is revolutionising industries across the board, and the pharmacy sector is no exception. As AI technology continues to develop, tools like ChatGPT are emerging as catalysts for change in how pharmacies operate. Probably the worst application of ChatGPT I’ve ever done, asking it for jokes for this image.

Customer Service 52

Customer Service Process Improvement Communication 52

Drug Patent Watch

APRIL 26, 2023

Annual Drug Patent Expirations for CLINDESSE Clindesse is a drug marketed by Padagis Us and is included in one NDA. It is available from one supplier. There are two patents… The post New patent expiration for Padagis Us drug CLINDESSE appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Quality Matters

APRIL 26, 2023

Essential elements of a strong, global medicines supply chain The U.S. Pharmacopeia (USP) has long been recognized as an international leader in medicines quality and supply chain integrity. In 2017, the Asia-Pacific Economic Cooperation (APEC) forum designated USP as an APEC Center of Excellence (CoE) through the sponsorship of the U.S. FDA. USP has advanced its leadership across the region through work that supports APEC economies in the dissemination and implementation of the APEC Supply Chai

Prescription Filling 52

Prescription Filling Generic Medicine Packaging Labelling 52

Drug Patent Watch

APRIL 26, 2023

Annual Drug Patent Expirations for VERKAZIA Verkazia is a drug marketed by Santen and is included in one NDA. It is available from one supplier. There are six patents protecting… The post New patent for Santen drug VERKAZIA appeared first on DrugPatentWatch - Make Better Decisions.

52

52

The Happy PharmD

APRIL 26, 2023

I was a staff pharmacist working in my first hospital. This was before I went back to school to get my advanced degree. This was even before I became a pharmacy manager. I liked working as a staff pharmacist in a hospital. From what I had heard, it was better than being a retail pharmacist. I was working the evening shift on that particular day. I started at 2:30 pm and worked until 11:00 pm.

Dosage 52

Dosage Hospitals Pharmacy Technician Prescription Filling 52

Drug Patent Watch

APRIL 26, 2023

Annual Drug Patent Expirations for SYNJARDY Synjardy is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are seven patents… The post New patent for Boehringer Ingelheim drug SYNJARDY appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Marketing Network

APRIL 26, 2023

This content is password protected. To view it please enter your password below: Password: The post Protected: Disease State Education – Creating a Strong Foundation for a Successful Launch appeared first on Pharma Marketing Network.

52

52

Drug Patent Watch

APRIL 26, 2023

Annual Drug Patent Expirations for GIMOTI Gimoti is a drug marketed by Evoke Pharma Inc and is included in one NDA. It is available from one supplier. There are two… The post New patent for Evoke Pharma drug GIMOTI appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Putting Patients First Blog

APRIL 26, 2023

International Patient Forum Event Time: 1:00 - 3:00 p.m. ET Event Location: Virtual IPF Home Register Schedule (Coming Soon) Speakers (Coming Soon) Sponsors Event Policies CAE Credits The post International Patient Forum appeared first on National Health Council.

52

52

European Pharmaceutical Review

APRIL 26, 2023

Construction has begun on Moderna ’s Innovation and Technology Centre (MITC) at the Harwell Science and Innovation Campus, Oxfordshire. Built to deliver Moderna’s ten-year strategic partnership with the UK government, announced in March 2023, the MITC will incorporate research, development and a manufacturing facility for mRNA vaccines. Moderna chooses mRNA vaccine manufacturing centre location The collaboration between the UK government and Moderna will provide “NHS patients across the country…

Vaccines 52

Vaccines 52